PEB Share Price
Open 0.48 Change Price %
High 0.48 1 Day 0.00 0.00
Low 0.48 1 Week 0.00 0.00
Close 0.48 1 Month -0.01 -2.04
Volume 177593 1 Year -0.10 -17.24
52 Week High 0.60
52 Week Low 0.43
PEB Important Levels
Resistance 2 0.48
Resistance 1 0.48
Pivot 0.48
Support 1 0.48
Support 2 0.48
NZE NewZealand Most Active Stocks
ATM 5.47 5.19%
ATM 5.47 5.19%
ATM 5.47 5.19%
ATM 5.47 5.19%
NPX 5.45 0.55%
NPX 5.45 0.55%
NPX 5.45 0.55%
TEL 2.87 0.00%
TEL 2.87 0.00%
TEL 2.87 0.00%
More..
NZE NewZealand Top Gainers Stocks
ALF 0.10 11.11%
MGL 0.36 5.88%
MGL 0.36 5.88%
ATM 5.47 5.19%
ATM 5.47 5.19%
ATM 5.47 5.19%
ATM 5.47 5.19%
AIR 3.52 3.23%
AIR 3.52 3.23%
AIR 3.52 3.23%
More..
NZE NewZealand Top Losers Stocks
TTK 0.73 -5.19%
TTK 0.73 -5.19%
SKT 2.80 -4.44%
SKT 2.80 -4.44%
SKT 2.80 -4.44%
TEN 0.36 -2.70%
TEN 0.36 -2.70%
TEN 0.36 -2.70%
TEN 0.36 -2.70%
TEN 0.36 -2.70%
More..

Pacific Edge Ltd (NZE: PEB)

PEB Technical Analysis 3
As on 24th Aug 2017 PEB Share Price closed @ 0.48 and we RECOMMEND Sell for LONG-TERM with Stoploss of 0.52 & Sell for SHORT-TERM with Stoploss of 0.49 we also expect STOCK to react on Following IMPORTANT LEVELS.
PEB Target for August
1st Target up-side 0.49
2nd Target up-side 0.52
3rd Target up-side 0.55
1st Target down-side 0.41
2nd Target down-side 0.38
3rd Target down-side 0.35
Pacific Edge Ltd ( NZE NewZealand Symbol : PEB )
Sector : Healthcare And Other Stocks in Same Sector
SAN
7.45 0.00 (0.00 %)
LT : Strong Buy
ST : Strong Buy		 AMP
5.40 0.00 (0.00 %)
LT : Buy
ST : Sell		 BLT
0.03 0.00 (0.00 %)
LT : Strong Sell
ST : Strong Sell		 BLT
0.03 0.00 (0.00 %)
LT : Strong Sell
ST : Strong Sell		 PHB
1.23 0.00 (0.00 %)
LT : Sell
ST : Sell
PEB Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.pacificedge.co.nz
PEB Address
PEB
 87 Saint David Street
PO Box 56
Dunedin, 9016
New Zealand
Phone: 64 3 479 5800
Fax: 64 3 479 5801
PEB Latest News
Pacific Edge Ltd (PEB.NZ) Sees Schaff Trend Cycle Trend Upward Near-Term   Financial Newsweek   - 23rd Aug 17
What Kind of Picture Are the Technicals Painting For Pacific Edge Ltd (PEB.NZ)?   Lenox Ledger   - 23rd Aug 17
Can Pacific Edge Limited (NZSE:PEB) Improve Your Portfolio Returns?   Simply Wall St   - 18th Aug 17
Pacific Edge Limited Full Year Results to 31 March 2017   Scoop.co.nz (press release)   - 24th May 17
Pacific Edge Undertakes $8m Share Placement   Scoop.co.nz (press release)   - 15th Feb 17
Pacific Edge announces commercial launch of Cxbladder Monitor in the US   News-Medical.net   - 15th Dec 16
Pacific Edge Launches Cxbladder Monitor™ in the United States   PR Newswire (press release)   - 13th Dec 16
Pacific Edge widens annual loss as it chases US growth   The National Business Review   - 26th May 16
Pacific Edge Presents Positive Cxbladder Monitor™ Results   PR Newswire (press release)   - 17th May 16
Research Shows Pacific Edge's Cxbladder Detect Outperforms Other Non-Invasive ...   PR Newswire (press release)   - 26th May 15
Interactive Technical Analysis Chart Pacific Edge Ltd ( PEB NZE NewZealand )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Pacific Edge Ltd
PEB Business Profile
Pacific Edge Limited, a biomedical company, engages in the discovery, development, and commercialization of diagnostic and prognostic tools for the early detection and management of cancer. It offers Cxbladder, a non-invasive urine based test for the detection of bladder cancer; and Cxcolorectal, a prognostic gene signature for patients diagnosed with stage II or stage III colorectal cancer. The company’s products in development and clinical trial stage include gastric cancer diagnosis and prognosis, gastric cancer triage, and melanoma diagnosis and prognosis. It also manages and operates laboratories for the detection of bladder cancer. The company was formerly known as Pacific Edge Biotechnology Limited and changed its name to Pacific Edge Limited in April 2010. Pacific Edge Limited was founded in 2001 and is based in Dunedin, New Zealand.